AAUS Alpha Architect US Equity ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| AAPL | 8.76% |
| NVDA | 7.62% |
| MSFT | 6.62% |
| GOOGL | 4.08% |
| AMZN | 3.78% |
| GOOG | 3.23% |
| AVGO | 2.69% |
| META | 2.34% |
| TSLA | 1.99% |
| JPM | 1.96% |
ETF Analysis
Fund Overview
Alpha Architect US Equity ETF (AAUS) currently reports 305 stock positions (subject to change), placing it in the index-like in breadth range by holdings breadth. The top line-up is AAPL (8.76%), NVDA (7.62%), MSFT (6.62%), with AAPL as the largest single weight at 8.76%. Together, the top three holdings account for 23.00%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.
Profitability & Capital Efficiency
On the question of capital productivity, ROIC is 38.27%, WACC is 9.56%, and the economic spread is 28.71%. On balance, the spread between returns and capital costs is exceptional, meaning reinvested capital is creating significant incremental value at the portfolio level. Supporting metrics show ROE at 50.29% and ROA at 14.58%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
From a market pricing perspective, trailing P/E of 26.50, forward P/E of 20.53, PEG of 2.04. A modest gap between trailing and forward multiples implies the market is pricing incremental earnings improvement rather than a step-change in profitability. On a growth-adjusted basis, valuation appears reasonable relative to expected growth. The portfolio carries an aggregate current ratio of 1.72, consistent with adequate near-term liquidity management. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.
Margins & Cash Generation
The margin stack reads as follows: gross margin sits at 55.39%, operating margin at 30.12%, and free cash flow margin at 22.20%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. FCF margins are constructive here, reflecting holdings that generate cash reliably after reinvestment requirements. The margin profile across gross, operating, and free cash flow levels is consistently strong — a rare combination that typically indicates durable business quality.
Growth & Forward Outlook
Where growth and expectations intersect, the estimated 12-month price change of 24.17%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 19.68% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 29.1% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyPutting all the pieces together, the fundamental picture is one of the more convincing setups in these metrics — strong capital returns, reasonable pricing, and a healthy forward outlook.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.